Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Nov 25;10(70):42983-42992.
doi: 10.1039/d0ra09051d. eCollection 2020 Nov 23.

Folic acid-sulfonamide conjugates as antibacterial agents: design, synthesis and molecular docking studies

Affiliations

Folic acid-sulfonamide conjugates as antibacterial agents: design, synthesis and molecular docking studies

Shabnam Shahzad et al. RSC Adv. .

Abstract

Dihydrofolate reductase (DHFR) inhibitors, as antibacterial agents, contain pyrimidine, pteridine, and azine moieties among many other scaffolds. Folic acid (FA), with a pteridine ring and amine group, was used as our focus scaffold, which was then conjugated with sulfonamides to develop new conjugates. The novel synthesized conjugates were characterized using infrared spectroscopy, and 1H and 13C nuclear magnetic resonance (NMR) spectral studies and consequently screened for antimicrobial activities against bacterial strains with ampicillin as a positive control. Compound DS2 has the highest zone of inhibition (36.6 mm) with a percentage activity index (%AI) value of 122.8% against S. aureus and a minimum inhibitory concentration (MIC) of 15.63 μg mL-1. DHFR enzyme inhibition was also evaluated using the synthesized conjugates through in vitro studies, and inhibition assays revealed that compound DS2 exhibited a 75.4 ± 0.12% (mean ± standard error of the mean (SEM)) inhibition, which is comparable with the standard DHFR inhibitor trimethoprim (74.6 ± 0.09%). The compounds attached to the unsubstituted aryl moiety of the sulfonamides revealed better inhibition against the bacterial strains as compared to the methyl substituted aryl sulfonamides. Molecular docking studies of the novel synthesized conjugates were also performed on the DHFR enzyme to identify the plausible binding modes to explore the binding mechanisms of these conjugates.

PubMed Disclaimer

Conflict of interest statement

We wish to confirm that there are no known conflicts of interest associated with this publication.

Figures

Scheme 1
Scheme 1. Synthesis of monosubstituted folic acid sulfonamides.
Scheme 2
Scheme 2. Synthesis of disubstituted folic acid sulfonamides.
Scheme 3
Scheme 3. Synthesis of trisubstituted folic acid sulfonamides.
Fig. 1
Fig. 1. Probable binding mode of the most active compound DS2 in the DHFR active site. (a) Superposition of docked DS2 (yellow) in the active site of the DHFR surface containing trimethoprim (cyan color). (b) Binding site (green sticks) containing 4A residues around the docked pose of DS2 (yellow), the white sticks are the NADPH substrate and the dotted lines (magenta) represent hydrogen bonding. Interatomic distances are shown in Angstrom.

Similar articles

Cited by

References

    1. Nitulescu G. Nicorescu I. M. Olaru O. T. Ungurianu A. Mihai D. P. Zanfirescu A. Nitulescu G. M. Margina D. Int. J. Mol. Sci. 2017;18:2217. doi: 10.3390/ijms18102217. - DOI - PMC - PubMed
    1. Raimondi M. V. Randazzo O. La Franca M. Barone G. Vignoni E. Rossi D. Collina S. Molecules. 2019;24:1140. doi: 10.3390/molecules24061140. - DOI - PMC - PubMed
    1. Singh A. Deshpande N. Pramanik N. Jhunjhunwala S. Rangarajan A. Atreya H. S. Sci. Rep. 2018;8:3190. doi: 10.1038/s41598-018-21435-5. - DOI - PMC - PubMed
    1. Wang N. Ren J.-X. Xie Y. J. Biomol. Struct. Dyn. 2019;37:1054–1061. doi: 10.1080/07391102.2018.1448721. - DOI - PubMed
    1. Qadir M. A. Ahmed M. Iqbal M. BioMed Res. Int. 2015;2015:7. - PMC - PubMed